Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease

Objective To evaluate the efficacy and safety of tin mesoporphyrin (SnMP) in neonates with hyperbilirubinemia (HB) due to hemolysis. Study Design This multicenter, placebo-controlled phase 2b study (NCT01887327) randomized newborns (35–42 weeks) with hemolysis started on phototherapy (PT) to placebo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of perinatology 2022-01, Vol.42 (1), p.110-115
Hauptverfasser:	Rosenfeld, Warren N., Hudak, Mark L., Ruiz, Nancy, Gautam, Shiva
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/1541 692/700/1720 Erythroblastosis, Fetal - therapy Female Heme Oxygenase (Decyclizing) Hemolysis Hemolytic disease Humans Hyperbilirubinemia Hyperbilirubinemia - therapy Hyperbilirubinemia, Neonatal - therapy Infant, Newborn Jaundice Light therapy Medicine Medicine & Public Health Metalloporphyrins Neonates Newborn babies Pediatric Surgery Pediatrics Phototherapy Placebos Tin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!